Corporate Banner
Satellite Banner
Mass Spectrometry
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Bruker Daltonics Launches Worldwide CLINPROT FORUM

Published: Monday, April 03, 2006
Last Updated: Tuesday, April 04, 2006
Bookmark and Share
The CLINPROT FORUM will support of customers in protein/peptide biomarker discovery and validation, as well as in clinical and applied proteomics.

Bruker Daltonics has announced the launch of its CLINPROT FORUM for the support of customers in protein/peptide biomarker discovery and validation, as well as in clinical and applied proteomics.

The CLINPROT™ product line (for research use only) covers various aspects of biomarker analysis with special emphasis on body-fluid and tissue profiling, MALDI molecular imaging, and protein/peptide-based micro-organism identification and classification. The CLINPROT solution includes magnetic bead sample pre-fractionation, MALDI-TOF analysis and streamlined bioinformatics and visualization tools.

The goal of the newly created international CLINPROT FORUM is to establish efficient networking amongst a rapidly growing worldwide community of CLINPROT users. This discussion forum covers various aspects of clinical proteomics, such as biofluid profiling and validation, biomarker identification, the MALDI Molecular Imager™ and the MALDI BioTyper™ for microorganism identification.

The CLINPROT FORUM facilitates efficient information exchange and should stimulate the formation of research collaborations between different laboratories. Special discussion threads include topics like sample preparation, standardization, biomarker identification and bioinformatics methods. A CLINPROT FORUM download site provides the latest protocols for sample preparation with CLINPROT magnetic beads, as well as recent publication lists and application notes.

The CLINPROT FORUM, which is moderated by expert Bruker application scientists, is available for all Bruker Daltonics customers and can be reached under http://clinprot.bdal.de.

Dr. Nils von Neuhoff, Head of Molecular Genetic Diagnostics, Institute of Cell and Molecular Pathology at Hannover Medical School, Germany, commented: "Researchers in the field of proteomic biomarker analysis and profiling of body fluids need to cover knowledge in diverse areas, like standardization of sample preparation, mass spectrometry and sophisticated mathematical approaches for pattern matching.

“Last but not least, they need to have a deep clinical knowledge concerning useful definitions of matching sample cohorts, anamnesis of patients and therapy decisions. For all those interdisciplinary tasks, it is very helpful to have the backup of a network of leading scientists from all over the world with special knowledge in different sub-disciplines of clinical proteomics. The collection and distribution of the latest protocols supplied in CLINPROT FORUM is of additional benefit for all participants."

Dr. Wolfgang Pusch, Assistant Vice President for Clinical Research Solutions at Bruker Daltonics, explained: "In our CLINPROT customer group, we have deep and diverse knowledge about biomarker analysis by means of mass spectrometry, but it is distributed all over the world from Asia/Pacific to Europe to the Americas. Some of these experts do not have the chance to meet personally and exchange information face-to-face on a regular basis."

" Our new CLINPROT FORUM will facilitate networking between our customers, and moreover accelerate the dissemination of best practices and protocols, of relevant recent literature and publications, as well as of timely CLINPROT method updates."


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
Gene Deletion Reveals Cell Secrets
Researchers have deleted 174 genes in yeast to analyse the effect of individual gene deletion.
Peer Reviewed Study Demonstrates Mass Spec Technique
The peer reviewed study demonstrates MS workflow, TMTCalibrator workflow, which dramatically enhances detection of key early stage Alzheimer’s biomarkers.
Impact of Emerging Contaminants in Our Water Supply
Emerging contaminants, any synthetic or naturally occurring chemical not commonly monitored in the environment, in our water supply are becoming of increasing concern due to their potential ecological and/or human health effects.
Collaboration to Develop Cannabis Testing Standards
SCIEX workflow solution enables cannabis labs to ensure product safety with robust, cost-effective analytical methods to facilitate routine testing.
Antibiotic Resistance Genes in Indoor Dust
Genetic analyisis of dust samples discovered antimicrobial chemicals and antibiotic-resistance genes.
Sharks Contain High Levels of Neurotoxins Linked to Alzheimer’s
Research team suggests restricting shark consumption to protect human health as shark fins & meat contain high levels of neurotoxins.
Peptide Mutants Help Identify Vulnerability in Tumor Cells
Researchers can detect mutant proteins based on MS data and the results of exome sequencing.
Diverse Fungi Secrete Similar Suite of Decomposition Enzymes
A recent study reveals different fungal species secrete a rich set of enzymes that share similar functions, despite species-specific differences in the amino acid sequences of these enzymes.
Misfiring Drugs Hit the Wrong Targets
Anti-HIV protein inhibitor drugs can bind to the wrong protein, causing unwanted side effects.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!